BCL2 and acute lymphoblastic leukemia: Approximately 15% of T-ALL cases display an early-thymic precursor (ETP) immunophenotype with absent/weak CD5 expression, cross-lineage expression of immature myeloid markers and a typical, dysregulated gene expression profile (JAK/STAT, FLT-3, BCL-2, etc.).